Quantcast
Environmental News for a Healthier Planet and Life

Single Dose of 'Magic Mushrooms' Provides Long-Term Anxiety Relief for Cancer Patients, Study Suggests

Health + Wellness
Single Dose of 'Magic Mushrooms' Provides Long-Term Anxiety Relief for Cancer Patients, Study Suggests
Psychedelic mushrooms are currently classified as a Schedule I drug by the FDA, and possession is a felony nationwide. juriskraulis / iStock / Getty Images

A single experience with "magic mushrooms" has long-lasting effects on cancer patients, according to a new study that found patients still felt positive benefits five years later, as CNN reported.


Not only did the patients feel reductions in anxiety, a slew of other mental health symptoms were relieved as well, including depression, hopelessness, demoralization and death anxiety, according to CNN.

In addition to self-reported improved well-being or life satisfaction, some patients rated the treatment as being "among the most personally meaningful and spiritually significant experiences of their lives," the authors wrote, as Medscape Medical News reported.

The study, published in the Journal of Psychopharmacology, followed up on a study published in 2016 that gave cancer patients a single dose of synthetic psilocybin, the psychoactive chemical present in mushrooms, in a controlled setting where the patients were monitored the entire time, as NBC News reported.

The study was featured recently in the documentary Fantastic Fungi.

The new follow-up tracked 15 of the first 29 participants from the study nearly five years after their guided experience with synthetic psilocybin. After five years, nearly 80 percent were still experiencing significant improvements in cancer-related depression and anxiety. Furthermore, almost all of the participants chalked up their positive life changes to the psychedelic-assisted therapy, according to NBC News.

"Our findings strongly suggest that psilocybin therapy is a promising means of improving the emotional, psychological, and spiritual well-being of patients with life-threatening cancer," said Dr. Stephen Ross, associate professor of psychiatry in the Department of Psychiatry at NYU Langone Health, as CNN reported.

"This approach has the potential to produce a paradigm shift in the psychological and existential care of patients with cancer, especially those with terminal illness," Ross added, as Medscape Medical News reported.

That said, it is important to note that this was a single controlled-dose from pharmacy-made synthetic psilocybin, and a trained nurse monitored the patients while they were under the influence of the narcotic. Possessing hallucinogenic mushrooms is a felony and ingesting them is potentially hazardous.

The researchers are not sure why psilocybin produced such long-lasting relief, but they previously theorized that it has to do with the brain's neuroplasticity — the brain's ability to adapt and change with various experiences, according to CNN.

"These results may shed light on how the positive effects of a single dose of psilocybin persist for so long," said Gabby Agin-Liebes, lead investigator and lead author of the long-term follow-up study, and co-author of the 2016 parent study. "The drug seems to facilitate a deep, meaningful experience that stays with a person and can fundamentally change his or her mindset and outlook."

One of the patients, Dinah Bazer, suffered from ovarian cancer in her 60s. After a successful round of chemotherapy, her anxiety inexplicably overwhelmed her.

"I thought that when the chemo ended, I would celebrate but instead, I went into a tailspin. Even though my prognosis was really excellent, I was worried about a relapse," Bazer said to NBC News. After her experience with synthetic psilocybin, Bazer went through six-months of no anxiety at all.

"What is permanent is that I don't have anxiety about cancer. Not only about my cancer returning, but how I viewed my reoccurrence when it did happen," said Bazer, who was diagnosed last March with a type of rare gastrointestinal cancer, as NBC News reported.

While the results are promising, they are limited because of the small number of patients in the study and the follow-up.

"The conclusions that can be drawn are limited because the original trial was a crossover design," said James Rucker, who leads the Psychedelic Trials Group at the Centre for Affective Disorders at Kings College London in the UK, to CNN. "This means that in the original trial every participant eventually received psilocybin. Because of this, there is no control group in this current study. This means that we do not know whether the participants might have improved long term anyway, regardless of the treatment."

However, Ross sees a bright future for the future of psilocybin in oncology.

"This could profoundly transform the psycho-oncologic care of patients with cancer, and importantly could be used in hospice settings to help terminally ill cancer patients approach death with improved emotional and spiritual well-being," Ross said, as CNN reported.

Yogyakarta Bird Market, Central Java, Indonesia. Jorge Franganillo / CC BY 2.0

By John R. Platt

The straw-headed bulbul doesn't look like much.

It's less than a foot in length, with subdued brown-and-gold plumage, a black beak and beady red eyes. If you saw one sitting on a branch in front of you, you might not give it a second glance.

Read More Show Less

EcoWatch Daily Newsletter

Red Knots are among the shorebirds that a scientific study is tracking. BrianEKushner / Getty Images

By Julián García Walther

One morning in January, I found myself 30 feet up a tall metal pole, carrying 66 pounds of aluminum antennas and thick weatherproofed cabling. From this vantage point, I could clearly see the entire Punta Banda Estuary in northwestern Mexico. As I looked through my binoculars, I observed the estuary's sandy bar and extensive mudflats packed with thousands of migratory shorebirds frenetically pecking the mud for food.

Read More Show Less

Trending

The Great Barrier Reef at Whitsunday Island, Australia. Daniel Osterkamp / Getty Images

The world's oceans and coastal ecosystems can store remarkable amounts of carbon dioxide. But if they're damaged, they can also release massive amounts of emissions back into the atmosphere.

Read More Show Less
For World Wildlife Day, seven "Champions of Nature" shared their picks for books that motivate them. Sam Edwards / Getty Images

By Kimberly Nicole Pope

During this year's Davos Agenda Week, leaders from the private and public sectors highlighted the urgent need to halt and reverse nature loss. Deliberate action on the interlinked climate and ecological crises to achieve a net-zero, nature-positive economy is paramount. At the same time, these leaders also presented a message of hope: that investing in nature holds the key to ensuring economic and social prosperity and resilience.

Read More Show Less
Protesters are seen during a demonstration in front of the White House in Washington, DC on June 1, 2017. Paul J. Richards / AFP / Getty Images

By Brett Wilkins

While some mainstream environmental organizations welcomed Tuesday's introduction of the CLEAN Future Act in the House of Representatives, progressive green groups warned that the bill falls far short of what's needed to meaningfully tackle the climate crisis—an existential threat they say calls for bolder action like the Green New Deal.

Read More Show Less